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ABSTRACT
egl-30 encodes the single C. elegans ortholog of vertebrate Gq family members. We analyzed the expression
pattern of EGL-30 and found that it is broadly expressed, with highest expression in the nervous system
and in pharyngeal muscle. We isolated dominant, gain-of-function alleles of egl-30 as intragenic revertants
of an egl-30 reduction-of-function mutation. Using these gain-of-function mutants and existing reduction-
of-function mutants, we examined the site and mode of action of EGL-30. On the basis of pharmacological
analysis, it has been determined that egl-30 functions both in the nervous system and in the vulval muscles
for egg-laying behavior. Genetic epistasis over mutations that eliminate detectable levels of serotonin
reveals that egl-30 requires serotonin to regulate egg laying. Furthermore, pharmacological response assays
strongly suggest that EGL-30 may directly couple to a serotonin receptor to mediate egg laying. We also
examined genetic interactions with mutations in the gene that encodes the single C. elegans homolog of
PLC and mutations in genes that encode signaling molecules downstream of PLC. We conclude that
PLC functions in parallel with egl-30 with respect to egg laying or is not the major effector of EGL-30.
In contrast, PLC-mediated signaling is likely downstream of EGL-30 with respect to pharyngeal-pumping
behavior. Our data indicate that there are multiple signaling pathways downstream of EGL-30 and that
different pathways could predominate with respect to the regulation of different behaviors.
CAENORHABDITIS elegans Gq is encoded by egl- 1996), it is likely that the biochemistry of signaling iswell conserved between C. elegans and mammals. We30 (Brundage et al. 1996). In mammals, on the
employed a genetic approach in C. elegans to furtherbasis of sequence similarity the Gq family is represented
characterize EGL-30-mediated signaling pathways. Toby four members: Gq, G11, G14, and murine G15/
this end, we screened for mutations that were able tohuman G16 (Wilkie et al. 1991). Mutations in egl-30
phenotypically suppress a reduction-of-function allele,were originally identified because of their egg-laying-
egl-30(md186). egl-30(md186) mutants are lethargic, ex-defective phenotype (Trent et al. 1983). Subsequent
hibit slow pharyngeal pumping, and lay eggs at a latercharacterization and identification of additional egl-30
stage of development than do wild type.mutant alleles revealed that egl-30 is involved with the
From our suppressor screen, two intragenic revertantsregulation of many behaviors, including egg laying
of egl-30(md186) that increase egl-30 function were iso-(Trent et al. 1983; Brundage et al. 1996), pharyngeal
lated. We used these mutants and another strong egl-30pumping (Brundage et al. 1996), movement (Brund-
gain-of-function mutant (Doi and Iwasaki 2002) as aage et al. 1996), viability (Brundage et al. 1996), and
tool to explore interactions with genes that encode can-spicule protraction (Garcia et al. 2001). The vertebrate
didate downstream molecules. Double-mutant strainsGq family is involved in pertussis-toxin-insensitive regu-
were constructed to analyze interactions with the PLC-lation of phospholipase C (PLC) isoforms (Exton
signaling pathway and to analyze interactions with re-1996). Like its vertebrate homolog, EGL-30 can stimu-
spect to the pathway defined as downstream of EGL-30late endogenous phospholipase activity in COS-7 cells
with respect to synaptic transmission (Lackner et al.(Brundage et al. 1996).
1999). We focused primarily on egg-laying behaviorGiven the fact that EGL-30 and Gq and G11 share
since this behavior is regulated by neural input to the80% identity at the amino acid level and that EGL-
vulval muscles by only two classes of motor neurons,30 can functionally complement Gq (Brundage et al.
the hermaphrodite-specific neurons (HSNs) and the
ventral type C neurons (VCs) (White et al. 1986; Wag-
goner et al. 1998). We also examined the double mu-
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served such that a tail spike and vacuolization of some of theOur results suggest that PLC, the only well-character-
nerve ring ganglia was apparent in the double mutant, butized effector for vertebrate Gq family members, is not not in either single mutant. In all cases, double mutants were
the only effector for EGL-30. With respect to egg laying, backcrossed to N2 and, after picking F1’s to individual plates,
PLC either acts in parallel to egl-30 or is a minor down- each single mutant was reisolated in the F2 progeny.
Construction and integration of functional GFP-taggedstream component of EGL-30-mediated signaling. Con-
EGL-30, hsp-16::egl-30(QL), and overexpression and integra-sistent with this result, mutations in itr-1, which encodes
tion of the wild-type egl-30 locus: Standard molecular biologi-the single inositol 1,4,5 triphosphate (IP3) receptor, and cal techniques were performed as described (Sambrook et
in a gene that encodes protein kinase C (PKC) also do al. 1989). For construction of an in-frame green fluorescent
not significantly modify egl-30 gain-of-function pheno- protein (GFP) fusion just 5 to the egl-30 initiator ATG, the
following primers were used to amplify a GFP S65T mutanttypes. However, with respect to pharyngeal pumping,
from a pRSET vector (kind gift from Roger Tsien): 5-AATeach of the mutations in genes that encode components
AAAGGCCTAAATGGCCATGAGTAAAGGAGAAGAACTTof PLC signaling do suppress egl-30 gain-of-function
TTC-3/5-TTAGCAGGCCATGGCGGCCAAGCATTTGTAT
phenotypes to a similar extent with respect to pharyn- AGTTCATCCATGC-3. The PCR product was gel purified
geal pumping. (QiaexII, QIAGEN, Valencia, CA), digested with SfiI, and
cloned into the SfiI site of pLB2 (Brundage et al. 1996). TheWe conclude that in C. elegans there are other effec-
resulting construct, pCB50, was injected into egl-30(md186);tor(s) for EGL-30 in addition to PLC and that different
dpy-20(e1282) at a concentration of 5 ng/l. Animals weredownstream pathways predominate to control egg lay- microinjected according to standard procedures (Mello et
ing and pharyngeal pumping. Expression analyses also al. 1991; Mello and Fire 1995). The dpy-20 rescuing plasmid,
indicate that there is not complete overlap with respect pMH86, was injected at 20 ng/l (Han and Sternberg 1990)
and was used as the coinjection marker. pBluescript was in-to EGL-30 localization and EGL-8 localization (Miller
cluded as carrier DNA to bring the total DNA concentrationet al. 1999). It is conceivable that different effector path-
to 200 ng/l.ways are cell-type specific, and we show that EGL-30 A fusion of the egl-30(Q205L) cDNA was cloned into pPD49.78
does function in, or via, at least one class of motor as a Kpn1-SacI fragment to generate pLB24. pLB24 was at
injected at 50 ng/l as described for pCB50.neurons that activate the vulval muscles and likely in
Transgenic arrays (pLB24 and pCB50) were chromosomallythe vulval muscles themselves as well.
integrated as described (Way et al. 1991), except that animals
were treated with 38 Gy from an X-ray source. The pLB24
integrant was named syIs38, and the pCB50 integrant was
MATERIALS AND METHODS named syIs105. Construction of and expression from the extra-
chromosomal array that was integrated (syEx125) to make
Manipulation of C. elegans : Maintenance and manipulation syIs36 by the procedures described for other integrated lines
of C. elegans were as described (Brenner 1974). The following (Brundage et al. 1996). The integrated lines were outcrossed
alleles were used for behavioral analyses and for double- a minimum of six times with dpy-20(e1282). The integration
mutant constructions: LGI, egl-30(md186)I (Miller et al. 1996), of the transgenic arrays generally increased the expressivity
egl-30(ad805)I (Brundage et al. 1996), and unc-13(e51) unc- of the phenotype observed in the nonintegrated lines. In the
122(n2916) I (Brenner 1974); LGII, tph-1(mg280)II (Sze et al. case of syIs38, the severity of the phenotype after heat shock
2000); LGIV, dpy-20(e1282)IV (Hosono et al. 1982), itr-1(sa73) also increased.
IV (Iwasaki et al. 1995), dpy-9(e12)IV (Brenner 1974), and Expression analysis: An EGL-30 antibody was generated in
tpa-1(k530)IV (Tabuse and Miwa 1983); LGV, egl-8(md1971)V rabbits against the C-terminal peptide: KDTILQHNLKEYNLV
(Miller et al. 1999), egl-8(n488)V (Trent et al. 1983), egl-8 (Quality Controlled Biochemicals). The antibody was affinity
(sa47)V (Thomas 1990), and egl-1(n487)V (Trent et al. 1983). purified with the peptide used for immunization using Sulfo-
The unc-13 strain used in this study (CB51) also contains a Link Coupling Gel (Pierce, Rockford, IL) according to the
linked unc-122 mutation. This linked mutation was uncovered manufacturer’s instructions. Indirect immunofluorescence
in Richmond et al. (1999) and was presumably used in all was done as described (Ruvkun and Giusto 1989), except
similar studies prior to this discovery (Lackner et al. 1999). 2 fixation buffer contained 50% MeOH and did not contain
In general, mutations were followed in crosses on the basis n-heptane, and Triton X-100 was used at 0.1%. Either a fluo-
of their own visible phenotypes. For strains harboring tpa-1, rescein-conjugated anti-rabbit antibody was used at 1:1000
dpy-9(e12) was used as a balancer, and for strains with itr-1, (Vector Laboratories, Burlingame, CA) or the Vectastain Elite
dpy-20(e1282) was used as a balancer in trans. For example, ABC avidin/biotin blocking kit was used with a biotinylated
egl-30(gf)/males were mated to dpy-9 hermaphrodites. Since anti-rabbit antibody (Vector Laboratories). When the biotinyl-
egl-30(md186sy676) is semidominant, it was possible to identify ated antibody was used, an avidin/biotin blocking step was
heterozygous male progeny. Hyperactive (egl-30(md186sy676)/ included after the collagenase digestion step. Animals were
; dpy-9/) F1 males were mated with tpa-1 mutant hermaph- examined with a Zeiss axioskop under a 100 objective. For
rodites. A total of 10 hyperactive (egl-30(md186sy676)/) F1 examination of GFP fluorescence, animals were examined on
progeny were selected and picked onto individual plates. A a Leica DMIRBE confocal microscope.
total of 25 candidate egl-30(md186sy676) homozygous animals Isolation of intragenic suppressor mutations: Ethyl meth-
were selected only from plates that segregated dpy-9. Plates anesulfonate (EMS) mutagenesis of 60,000 egl-30(md186)
that segregated only hyperactive non-Dpy progeny were exam- gametes was done as described (Brenner 1974) using 50 mm
ined for progeny that segregated hyperactive animals of which EMS. From this screen, we isolated two intragenic revertants
approximately one-fourth had a modified phenotype. In the and three strong extragenic suppressor mutations. F2 progeny
cases of itr-1 and tpa-1, both mutations slightly modified the were selected on the basis of their ability to suppress egg-
movement of egl-30(gf) homozygotes. egl-30(gf); itr-1(sa47) ani- laying and/or movement defects of egl-30(md186) mutants.
mals were scrawnier than egl-30(gf) homozygotes and in egl- Intragenic suppressor mutants were outcrossed to N2 at least
six times.30(gf); tpa-1 double mutants a synthetic phenotype was ob-
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Sequencing of egl-30 mutations: Suppressor mutations (sup) worms in PBS buffer containing 1 mm magnesium chloride
and 0.4% SDS. Worms were stained for 1 hr at room tempera-were picked as potential intragenic revertants on the basis of
the inability to isolate egl-30(md186) homozygous F1 progeny ture, harvested, and washed three times in PBS containing
0.5% Tween-20. Animals were examined for fluorescence onwhen sup egl-30(md186)/ males were mated to egl-30
(md186). Fragments of the egl-30 locus were amplified using a Zeiss axioscope.
Western analysis: Worms were harvested from NGM platesTakara LA-Taq (PanVera) with the following primer sets:
5-GCATCGAACTTCTATCCTC-3/5-GCTACGAGATATTT in M9 and washed one time with M9. Worm pellets were
resuspended in 2 SDS sample buffer (Novex, San Diego)GTTGC-3 (exons 1 and 2), 5-GAGATTAAAATACTCAT
TTCG-3/5-CGAAAAAAGCATCAGAGATTG-3 (exons 3–5), and heated at 70 for 10 min. Worm debris was pelleted at
14 K in a microcentrifuge for 10 min, and the supernatantand 5-CTTTCTGTAAATTGTCAGC-3/GTGGTGTCTCACTC
GACC-3 (exons 6–8). DNA was amplified in 10 50-l reactions, was promptly loaded on an SDS/PAGE gel (Novex).
For Western analysis of EGL-30, the same number of syIs36gel purified using Qiaex II (QIAGEN), and directly sequenced
on an automated sequencer (ABI). The DNA was compared mutants was first picked to separate plates for each time point.
Four days later (prior to starvation) worms were heat-shockedwith N2 and with the original egl-30(md186) strain. Mutations
were confirmed by sequence from the reverse strand. Muta- for 30 min at 32. At the indicated time points, worms from
each plate were harvested and prepared as described above.tions were mapped onto known crystal structures using Protein
Explorer (http://www.umass.edu/microbio/chime/explorer/ Worm extracts were loaded onto a 10% gel.
For analysis of egl-8 expression, worms were harvested inindex.htm). egl-30(tg26) was isolated in a screen for suppressors
of unc-31 by L. Khan (Doi and Iwasaki 2002) and obtained M9 as above. Extracts for analysis of egl-8 expression were
loaded onto a 4–12% gradient gel (Novex).as a generous gift from the Iwasaki laboratory.
Sequencing of egl-8 mutations: Primers flanking the n488 Electrophoretic transfer was carried out for 1.5 hr for EGL-
30 Western analysis and overnight for EGL-8 analysis. Follow-deletion were used for PCR: 5-CTA CTA CCC AAC AAG TGA
GAG 3/5-CGG AAG TTT TGG GCT GTT TTG G-3. The ing transfer to nitrocellulose membranes, EGL-8 antibody
(generously provided by Kenneth Miller) was used at a concen-deletion was found to extend from 7905–9735 in the unspliced
DNA sequence displayed in WormBase (WS62) such that the tration of 1:1000 (Miller et al. 1999), and affinity-purified
EGL-30 antibody generated against the peptide was used at asequence 5-GTGTGGGAAAAAATGTGT-3 was fused to
5-TGTTGATTATCATTTTCT-3. Primers flanking the dilution of 1:50,000. HRP-linked anti-rabbit IgG (Amersham,
Buckinghamshire, UK) was added at a concentration ofmd1971 mutation were used for PCR: 5-CGA AGA CCC GAC
1:1000, and bands were visualized using enhanced chemilumi-AGA ACA TT-3/5-CCC GGG TAT TAC CTT CGT CT-3. PCR
nescence (Amersham).products were amplified, purified, and sequenced as above.
Behavioral assays: To measure pharyngeal pumping rates, 1-
day-old adults were placed on nematode growth media (NGM)
RESULTSplates seeded with OP50 and left undisturbed for at least 15
min before counting. Pharyngeal pumps were measured using
Expression of egl-30: To clarify the site and mode ofa counter for a period of 3 min. Response was measured only
action for egl-30 with respect to the behaviors that itfrom animals that remained in food throughout the period
of observation. regulates, to resolve differences in the inferred site-
To characterize egg-laying behavior, animals were examined of-action from previous reports (Brundage et al. 1996;
24–28 hr after selecting them as L4 larvae. Young adults were Lackner et al. 1999), and to examine the subcellularplaced on fresh plates seeded with OP50 and newly laid eggs
localization of egl-30, we sought to construct a rescuingwere examined every 5 min for their developmental stage
GFP fusion transgene. This transgene contains all ofusing a Wild M420 macroscope and then removed from the
plate. In all cases, at least two trials were performed on differ- the presumptive 5-transcriptional regulatory sequences,
ent days, and at least 10 different adults were assayed per trial. introns, and presumptive 3 regulatory sequences for
For mutants that never laid eggs past the gastrulation stage egl-30, in addition to the coding sequences for GFP just
of development, at least three trials were performed.
5 of the egl-30 initiating methionine. We expected thatFor response to 5-hydroxytryptamine (5-HT; Sigma, St.
this transgene should be appropriately expressed as wellLouis), levamisole (Sigma), and -methyl 5-hydroxytrypta-
as appropriately localized. This transgene was integratedmine (-methyl 5-HT; Sigma), animals were tested singly (ex-
cept as indicated) as 1-day-old adults in wells of a microtiter into the genome of egl-30(md186) animals, and the inte-
plate containing a solution of the indicated drug. Response grated transgene, syIs105, was found to partially rescue
was measured after 60 or 90 min, as indicated in figure legends. egl-30(md186) with respect to egg laying, movement, pha-5-HT was generally used at a concentration of 7.5 mm, levami-
ryngeal pumping, and response to neurotransmitters insole at 6.25 m, and -methyl 5-HT at 1 mm. For 5-HT and
egg-laying assays (Tables 1 and 2). Expression was firstlevamisole, we used M9, but sodium phosphate was substituted
for potassium phosphate. To test response to -methyl 5-HT, observed in early embryos at cell peripheries and in
assays were performed in water since M9 inhibited the re- a punctate pattern throughout embryos (Figure 1D).
sponse for all genotypes tested, except for strains that also Later, expression was observed in larvae in the nervecontained egl-1 mutations.
ring and many neurons of the nerve ring ganglia, pha-Phalloidin staining: Worms were stained with phalloidin
ryngeal muscle, and ventral cord and many neurons inusing a modification of a previously described protocol
(Myers et al. 1996). Worms were grown on NGM plates, har- the tail ganglia and hypodermis (Figure 1). Highest
vested in S-basal medium, and washed once with S basal. Super- expression levels were observed in L4 larvae and in adult
natant was removed with a Pasteur pipette and worms were animals. In the nervous system, expression was observed
frozen in liquid nitrogen. A few drops of ice-cold acetone were
in cell bodies and in neural processes. However, theadded to worms and worms were incubated on ice for 5 min.
highest expression was observed in the axons of theAcetone was removed and worms were air dried. A total of
10 g of fluorescein-conjugated phalloidin was added to the nerve ring. Expression in larvae and in adults was also
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TABLE 1
egl-30(md186) mutants exhibited defective egg-laying and pharyngeal-pumping phenotypes
Stages at which eggs were laid
5c-gastr. (%) Comma (%) 2-fold (%) Pretzel (%) Hatched (%) N
N2 100 Many
egl-30(md186) 1 5 48 46 100
egl-30(md186)/ 79 9 9 3 43
egl-30(md186); syls105 100 37
Pharyngeal pumps/min N SD
N2 277.9 5 9.3
egl-30(md186) 174.7 5 12.3
egl-30(md186)/ 223.8 5 9.4
egl-30(md186); syls105 217.7 5 8.4
egl-30(md186) is a reduction-of-function mutation and exhibits haplo-insufficiency, like other egl-30 reduction-
of-function alleles previously described (Brundage et al. 1996). GFP-tagged EGL-30 rescued egl-30(md186) with
respect to egg-laying and pharyngeal-pumping defects. The integrated transgene, syls105, was used to analyze
the expression pattern of egl-30. SD, standard deviation for the number of pumps per minute. 5c-gastr., from
five-cell stage embryo to gastrulation; 2-fold, twofold stage embryo.
evident in the pharyngeal muscle. Expression was also in the ventral nerve cord were also observed to occasion-
ally express GFP.observed in the dorsal nerve cord and in sublateral
processes (Figure 1E). In addition, occasional expres- Immunolocalization analysis with a polyclonal anti-
body generated against the carboxyl terminus of EGL-sion was observed throughout the intestine (particularly
in the posterior intestine), vulval muscle, head muscle, 30 generally revealed the areas with highest expression
levels. Using an HRP-conjugated secondary antibodyin sperm, tonofilaments, and in vulval cells. With the
exception of the pharyngeal muscle, expression levels and a FITC-conjugated secondary antibody, we observed
high expression in axons of the nerve ring. The FITC-in muscle were generally extremely low such that only
rare animals (10%) showed weak expression. The CAN conjugated antibody also indicated expression in pha-
ryngeal muscle. Both secondary antibodies revealed ex-cell bodies and associated canals were observed to ex-
press GFP-tagged EGL-30 in most animals (Figure 1C). pression in sperm, and the FITC-conjugated antibody
consistently showed expression in the anal sphincterThe HSN cell bodies and the VC4 and VC5 neuronal
cell bodies also occasionally expressed EGL-30 (10%), muscle (Figure 1H). Nonspecific antibody staining was
observed in intestinal nuclei using both secondary anti-on the basis of proximity to the vulva. Other cell bodies
TABLE 2
Egg-laying response of 1-day-old adult hermaphrodites to pharmacological agonists
5-HT Levamisole  5-HT
Genotype Response N SD Response N SD
N2 5.0 23 2.7 3.7 15 0.6
egl-30(md186) 1.9 10 2.6 0.5 15 0.1
egl-8(md1971) 9.3 12 4.1
egl-8(n488) 0 19 0 0.3 15 0
egl-8(sa47) 9.3 10 4.4
unc-13(e51) 4.4 11 3.7
egl-30(md186); syls105 5.5 22 3.1 8.2 15 0.3
Controls in M9 were performed on each strain. Only egl-30(md186); syls105, which contained the integrated
egl-30::GFP transgene, responded by laying an average of 1.8 eggs per worm in M9. To measure response to
7.5 mm 5-HT, single worms were assayed in a total volume of 150 l. Eggs were counted after a 90-min
incubation at room temperature. SD, standard deviation per worm. To measure response to 7.5 mm 5-HT and
6.25 m levamisole, five worms were assayed in a total volume of 150 l. Eggs were counted after a 1-hr
incubation at room temperature. SD, standard deviation per five worms.
1809C. elegans Gq Expression and PLC Signaling
Figure 1.—Expression of egl-30, based on an
integrated GFP fusion transgene (A–F) and indi-
rect immunofluorescence (G and H). (A) The
arrow indicates expression in the nerve ring. The
arrowhead indicates expression in the pharyngeal
muscle. (B) Arrow indicates expression in the ven-
tral nerve cord. (C) Arrow indicates expression
in the CAN neuron. (D) Arrow points to expres-
sion in the vulval muscle. (E) Expression in nerve
tracts. (F) Expression in the VC4 and VC5 motor
neurons, based on their positions, is indicated by
the arrow. (G) Expression in the nerve ring, as
detected using a biotinylated secondary antibody
and HRP-avidin. (H) Expression in the anal
sphincter muscle, as visualized with a FITC-
labeled secondary antibody. Images in A–F were
obtained with a Leica DMIRBE microscope and
images in G and H were obtained on a Zeiss axio-
scope.
bodies and is most likely due to cross-reactivity with an egl-30 transgene (Figure 2A). When egl-30 was overex-
pressed from an integrated array (syIs36), an increaseunrelated protein. Western analysis supports this hy-
pothesis since the band that migrates at the position in the intensity of staining was observed in the nerve
ring and in pharyngeal muscle, but not in intestinalwhere EGL-30 migrates on an SDS/PAGE gel is present
at almost equivalent intensities in protein extracts pre- nuclei.
The broad expression pattern of egl-30 is consistentpared from egl-30(ad805) mutants compared to wild-type
extracts (data not shown), but the levels of this band with its pleiotropic and essential function. Expression
levels of egl-30 were clearly higher in the nervous systemincrease significantly after heat-shock induction of an
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comma stage of development. egl-30(md186) mutants
also exhibited semidominance with respect to pharyn-
geal-pumping and egg-laying defects (Table 1). Conse-
quently, it is clear that reducing activity levels of EGL-
30 by 	50% has significant phenotypic consequences.
Similarly, raising both expression or activity levels of
EGL-30 has drastic effects on behavior (Brundage et
al. 1996). A transgenic strain that overexpresses wild-
type egl-30 under its own regulatory regions, syIs36, ex-
hibited hyperactive movement, moved with exaggerated
body bends, and laid eggs at an early stage of develop-
ment (data not shown and Table 3). These animals
also exhibited a pale, starved appearance. Heat-shock
induction of syIs38, an integrated transgene that con-
tains a gain-of-function cDNA of egl-30 fused to the hsp-
16-2 enhancer-promoter element, demonstrated the
progressive effects caused by increasing EGL-30 expres-
sion and activity levels over time. Approximately 2 hr
after a heat-shock induction of 32 for 30 min, worms
became hyperactive, started to move with exaggerated
body bends, and had laid all of the eggs contained
within their uteri (Figure 2B). After 4 hr, worms became
paralyzed and hypercontracted. After 24 hr, the hyper-
Figure 2.—Heat-shock induction of EGL-30(Q205L) under contracted phenotype was still apparent, and animals
the control of the hsp-16-2 promoter element (integrant exhibited weak but constitutive pumping of all muscle
syls38). (A) Protein levels following a 30-min heat shock at types and displayed vacuolization of many cell types
32. Times indicated represent the amount of time following
(Figure 2B). Eventually, these worms died. These effectsthe end of the heat-shock regimen. Protein levels did not
are evident in spite of the fact that expression levels ofappear to increase more than threefold above basal levels.
(B) Phenotypic effects on adults following heat shock. After egl-30 increased only at most threefold above endoge-
2 hr worms exhibited a hyperactive phenotype, laid early eggs, nous levels (Figure 2A). This low induced level of ex-
and moved with exaggerated body bends. Within 4 hr, animals pression is in marked contrast to the high induced levels
were completely paralyzed. Twenty-four hours later, adults
of expression that were obtained with an analogousdisplayed a hypercontracted posture, constitutive pumping of
GOA-1 construct (C. Bastiani, W. Chen, M. I. Simonmany muscle types, and exhibited vacuolization of many cells.
and P. W. Sternberg, unpublished results). The same
differences in expression levels are observed when levels
of GOA-1 and EGL-30 are compared after transfectionand in pharyngeal muscle, suggesting that EGL-30 ex-
erts a primary role in these tissues. Weak or occasional of cDNA expression plasmids into HEK293T cell lines
(C. Bastiani, W. Chen, M. I. Simon and P. W. Stern-expression in other muscle-cell types, sperm, intestine,
tonofilaments, and vulval cells indicates the possibility berg, unpublished results).
Gain-of-function mutants of egl-30: Mutations that dothat EGL-30 might have an almost ubiquitous expres-
sion pattern. not affect expression levels of egl-30, on the basis of
Western blot analysis (data not shown), similarly demon-Dose sensitivity of egl-30: Haplo-insufficiency of the
egl-30 locus, together with phenotypic analysis of gain- strate the effects of altered activity levels of EGL-30. Two
intragenic revertants of a reduction-of-function allele,and reduction-of-function mutations in egl-30, demon-
strates that perturbations in activity levels of egl-30 result egl-30(md186), were obtained in screens for mutations
for suppression of the allele’s egg-laying-defective andin a clear phenotypic readout. Heterozygous reduction-
of-function mutants exhibit semidominance with re- lethargic phenotypes (Tables 3 and 4 and data not
shown). egl-30(md186) encodes a D201E change immedi-spect to lethargic locomotion and egg-laying defects
(Brundage et al. 1996). egl-30(md186) mutants behaved ately adjacent to the switch 2 region, suggesting that
association with guanine nucleotides is probably altered.like other reduction-of-function mutations previously
described and lay 94% of their eggs after the gastrula- The two intragenic revertants differ in their strengths.
The stronger intragenic suppressor mutant, sy676,tion phase of development (Table 1). Wild-type her-
maphrodites lay eggs 2–3 hr after fertilization during exhibited semidominant hyperactive movement, move-
ment with exaggerated body bends, and constitutivethe gastrulation phase (beginning at the 28-cell stage) of
development and always before morphogenesis begins egg-laying phenotypes (heterozygotes lay 19% of eggs
at or before the four-cell stage; N 
 224), similar to(comma stage; Sulston et al. 1983). For our purposes,
late-stage eggs are defined as eggs laid at or after the phenotypes caused by overproduction of wild-type EGL-
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TABLE 3
Genetic interactions with respect to egg laying of egl-30 mutations with mutations in genes that encode candidate
downstream-signaling molecules
Stages at which eggs were laid
Behavior 1–4c (%) 5c-gastr. (%) Comma (%) 2-fold (%) Pretzel (%) Hatched (%) N
N2 WT 100 Many
syls36 Egl-C 88 12 12
egl-30(md186sy676) Egl-C 42 58 224
egl-30(md186sy676); egl-8(sa47) Egl-C 24 76 71
egl-30(md186sy676); egl-8(n488) Egl-C 36 64 52
egl-30(md186sy676); egl-8(md1971) Egl-C 37 63 71
egl-30(md186sy676); tpa-1(k501) Egl-C 59 41 63
egl-30(md186sy676); itr-1(sa73) Egl-C 25 75 91
egl-30(md186sy676); unc-13(e51) Egl-D 93 2 2 3 61
egl-30(tg26) Egl-C 91 9 51
egl-30(tg26); egl-8(sa47) Egl-C 78 22 78
egl-30(tg26); egl-8(n488) Egl-C 79 21 47
egl-30(md186sy679) Egl-D 71 15 2 12 93
egl-30(md186sy679); egl-8(sa47) Egl-D 33 29 2 36 45
egl-30(md186sy679); unc-13(e51) Egl-D 36 11 7 39 7 61
egl-30(md186) Egl-D 1 5 48 46 100
egl-30(md186); egl-8(sa47) Egl-D 3 31 3 63 32
egl-30(md186); unc-13(e51) Egl-D 50 19 3 27 4 119
egl-8(sa47) Egl-D 62 16 18 4 45
egl-8(n488) Egl-D 8 21 14 51 6 47
egl-8(md1971) WT 100 40
tpa-1(k501) WT 100 55
itr-1(sa73) WT 100 86
unc-13(e51) Egl-D 29 21 48 2 58
Assays were performed on 1-day-old adults after transferring 10 worms to fresh plates. Trials were performed on at least two
separate days. The differences between the percentage of eggs laid at the one- to four-cell (1c–4c) stage between egl-30(md186sy676)
single and double mutants with egl-8, tpa-1, and itr-1 mutations were not significant on the basis of the Kruskal-Wallis nonparametric
ANOVA test (two-tailed P value  0.2). The differences were also not significant between the egl-30(tg26) single and double
mutants (two-tailed P value	 0.2). unc-13 mutations suppressed hyperactive egg laying conferred by egl-30(md186sy676) mutations,
but egl-30(676) mutations partially suppressed the Egl-D phenotype conferred by unc-13 mutations. WT, wild type. 5c-gastr., five
cell to gastrulation.
30 (Brundage et al. 1996). This intragenic revertant ture of Gi in a complex with / (Wall et al. 1995),
we know that this mutation lies in a region that likelyencodes a R334W change within the 5 helix. This
amino acid change results in a string of eight consecu- does not affect interaction with /. In addition, align-
ments with mammalian Gi indicate that this mutationtive hydrophobic residues, of which W334 is the second.
Mutations of residues within the 6/5 loop promote does not lie in a region important for activation of PLC
(Venkatakrishnan and Exton 1996). Consequently,dissociation of GTP and GTP/GDP exchange on several
G subunits (Thomas et al. 1993; Iiri et al. 1994; Posner we speculate that GTP dissociation, GTP/GDP exchange,
or interaction with seven-pass membrane receptors iset al. 1998). This region also lies very close to the car-
boxyl terminus of EGL-30, which in G subunits is impli- affected by this mutation.
The weaker intragenic suppressor mutation, sy679,cated in interactions with membrane receptors (Hamm
et al. 1988; Garcia et al. 1995; Osawa and Weiss 1995; encodes an E277K change, a change from an acidic
residue to a basic residue, within the G helix. On theKisselev et al. 1998). On the basis of comparative analy-
sis with the crystal structure of Gi in a complex with crystal structure of Gi (Raw et al. 1997), this mutation
is in close proximity to the residues involved in guanineRGS4 (Tesmer et al. 1997), it is likely that the mutated
amino acid does not directly interact with the site of ring binding and is diametrically opposite from the orig-
inal egl-30(md186) mutation (Figure 3). It is possible thatthe original egl-30(md186) mutation (Figure 3). Also on
the basis of comparative analysis with the crystal struc- this mutation partially compensates for any alterations
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TABLE 4
Interactions with respect to pharyngeal-pumping behavior of
egl-30(gf) and egl-30(rf) mutations with mutations in genes that
encode candidate downstream signaling molecules
Pumps/min SD
N2 277.9 9.3
egl-30(md186sy676) 300 NA
egl-8(sa47) 186.2 3.3
egl-30(md186sy676); egl-8(sa47) 206.4 11.0
itr-1(sa73) 79.8 32.7
egl-30(md186sy676); itr-1(sa73) 134.2 20.8
unc-13(e51) 84.1 18.7
egl-30(md186sy676); unc-13(e51) 186.6 4.9
egl-30(md186) 174.7 12.3
egl-30(md186); egl-8(sa47) 106.7 27.0
egl-30(md186); unc-13(e51) 2.4 1.1
Pumping assays were performed on 1-day-old adults as de-
scribed in materials and methods. SD, standard deviation
per worm. NA, not applicable. Figure 3.—Mutations in egl-30 positioned on the crystal
structure of rat Gi1 bound to GDP, AIF4 , and Mg2 in a
complex with RGS4 (Tesmer et al. 1997). Blue and green
in guanine nucleotide interactions modified by the orig- chains show Gi1 -, -, and -subunits. RGS4 chains are shown
in red and yellow. Two citrate ions are positioned within theinal egl-30(md186) mutation. However, E277K did not
Gi1 dimer interface.completely suppress the original D201E change in egl-
30(md186) with respect to pharyngeal pumping (data
not shown) and egg laying (Table 3). Again, on the
The PLC-signaling pathway is not the predominantbasis of comparative crystal structure analysis, / inter-
pathway downstream of EGL-30 with respect to egg lay-actions are probably not affected.
ing: Mammalian Gq family members are believed toAnother gain-of-function mutant, egl-30(tg26), was ob-
principally activate isoforms of PLC (Lee et al. 1992).tained in a screen for suppressors of unc-31 (Doi and
PLC hydrolyzes phosphatidylinositol 4,5-bisphosphateIwasaki 2002). tg26 encodes an R243Q change (Doi
(PIP2) into the signaling molecules diacylglycerol (DAG)and Iwasaki 2002), and this mutation is contained
and IP3. DAG activates PKC while IP3 activates releasewithin the switch III region of the 3 helix, indicating
of calcium from intracellular stores via activation of thethat R243Q probably alters guanine nucleotide binding
IP3 receptor, a calcium channel. egl-8 encodes the only(Figure 3). tg26 is also semidominant (heterozygotes lay
recognizable PLC isoform in the worm and is most23% of eggs at or before the four-cell stage; N 
 44)
closely related to vertebrate PLC4. egl-8 reduction-and confers the most severe gain-of-function pheno-
of-function mutants exhibit lethargic locomotion and atypes compared with the two other mutants. Mutants
reduced rate of pharyngeal pumping, and they lay late-moved with exaggerated body bends and laid eggs at
stage eggs (Trent et al. 1983; Miller et al. 1999; Tablesan earlier stage of development than wild type did (Ta-
3 and 4), as do egl-30 reduction-of-function mutants.ble 3). In addition, brood sizes were significantly lower
However, a candidate null allele in egl-8 (Lackner et al.than those in egl-30(md186sy676) mutants (77  44 vs.
1999) is not as severely impaired as egl-30 reduction-175  32). Unlike the egl-30(md186sy676) mutant, but
of-function mutants with respect to egg laying and loco-like syIs36 that overexpresses wild-type egl-30, the pharyn-
motion (Table 3 and data not shown). In addition, egl-8geal pumping exhibited by these mutants would alter-
mutants are fully viable, unlike egl-30 severe loss-of-func-nate from a very fast rate to no visibly evident pumping,
tion alleles (Brundage et al. 1996), suggesting thatpossibly due to tonic contraction of these muscles.
EGL-8 is not the only downstream effector for EGL-30.In summary, haplo-insufficiency of the egl-30 locus,
Three alleles of egl-8 have been previously describedthe semidominance of the gain-of-function mutants,
with respect to their molecular lesions. egl-8(sa47) en-and the progressive phenotypes caused by heat-shock-
codes an early termination codon and is presumed toinduced overexpression of a gain-of-function transgene
be a null allele (Lackner et al. 1999). egl-8(md1971)demonstrated a clear phenotypic readout when levels
encodes a premature termination codon 3 of the C2of egl-30 expression or activity were altered. Given this
domain (although the mutation was predicted to beresult, if there is only one primary downstream effector
contained within the catalytic Y domain as reported;for egl-30, a knockout or near knockout in a primary
Miller et al. 1999). egl-8(n488) deletes 1.8 kb of se-downstream effector should strongly suppress egl-30
gain-of-function mutations. quence including exons 10 and 11 (Miller et al. 1999).
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Unlike egl-30 reduction-of-function mutants, sa47 and stood at this point. The most likely possibility is that
the egl-30(md186); egl-8(sa47) larvae are more seriouslymd1971 exhibit a strong induction of egg laying in re-
sponse to 5-HT (serotonin; Table 2). On the basis of impaired with respect to movement and are therefore
not as competent to crawl out of the mother. Thesephenotypic similarities with egl-8(sa47), egl-8(md1971) is
likely a partial reduction-of-function allele (Table 2). results indicate either that egl-8 is a minor effector for
egl-30 or that egl-8 functions completely in parallel withLike egl-30 reduction-of-function mutations, but unlike
sa47 and md1971, egl-8(n488) mutants are completely egl-30 with respect to egg laying and possibly movement.
unc-13 single mutants displayed a severe egg-layingresistant to serotonin in egg-laying assays (Trent et al.
1983). egl-8(n488) is the canonical egl-8 allele and has defect, and unc-13(e51) mutations did suppress constitu-
tive egg laying conferred by egl-30(gf) mutants (Tablebeen the only allele previously tested for pharmacologi-
cal response in egg-laying assays. 3). However, double mutants were not nearly as im-
paired with respect to egg laying as unc-13 single mutantsTo investigate the interaction between C. elegans Gq
and PLC, we constructed strains defective in egl-30 as were. The observation that egl-30(md186); unc-13 double
mutants are apparently less defective in egg laying thanwell as in genes that encode components of the PLC-
signaling pathway. Interactions were examined with the either single mutant may reflect the fact that acetylcho-
line must exert both a positive and a negative regulatorythree alleles of egl-8 described above: egl-8(sa47), egl-8
(md1971), and egl-8(n488) (Table 3). We also examined role in egg laying; cha-1 mutants lay early embryos and
are hypersensitive to serotonin (Schafer et al. 1996).interactions with itr-1, tpa-1, and unc-13 mutations. itr-1
encodes the only IP3 receptor homolog in the worm C. elegans UNC-13 is known to affect evoked neuro-
transmitter release at both GABAergic and cholinergic(Clandinin et al. 1998; Baylis et al. 1999; Dal Santo et
al. 1999) and loss-of-function mutations were originally synapses, but it has not been shown to affect serotonin
release (Richmond et al. 1999). The unc-13(e51) alleleisolated because of their defecation defects (Iwasaki
et al. 1995). tpa-1 encodes a protein most similar to appears to almost fully compromise the function of
UNC-13, as assessed by measuring evoked responses invertebrate PKC and was identified since mutations in
the gene that encode TPA-1 confer resistance to TPA muscle by whole-cell patch clamp recordings in response
to stimulation of the ventral nerve cord (Richmond et(Tabuse and Miwa 1983; Tabuse et al. 1989). UNC-13
is also implicated in a pathway downstream of DAG al. 1999). Acetylcholine is a known positive regulator
of egg-laying behavior (Waggoner et al. 1998), andsince the discovery that its mammalian ortholog,
mUNC-13, is a receptor for DAG and enhances neuro- a role for EGL-30 in the regulation of the release of
acetylcholine from motor neurons has previously beentransmitter release (Betz et al. 1998). Later, UNC-13
was found to regulate acetylcholine and GABA release reported (Lackner et al. 1999). Our analysis of egg-
laying behavior suggests either that the regulation offrom neuromuscular junctions in C. elegans (Lackner
et al. 1999; Richmond et al. 1999) and to be essential acetylcholine release is not the only neuronal pathway
downstream of EGL-30 or that EGL-30 function in thefor neurotransmitter release in Drosophila melanogaster
(Aravamudan et al. 1999). vulval muscle can partially bypass the requirement for
acetylcholine.To analyze epistasis, we constructed all double mu-
tants using egl-30(md186sy676) and confirmed selected tpa-1 is the only PKC in the worm for which mutations
have been identified (Tabuse et al. 1995). tpa-1 encodesinteractions using egl-30(tg26), because the egl-30(md186
sy676) strain does not exhibit the pale, scrawny, starved a protein with similarity to PKC. Loss-of-function tpa-1
(k501) mutants lay eggs at significantly lower rates thanappearance of egl-30(tg26) and has a brood size compara-
ble to wild type. egl-30(gf) mutants exhibited a constitu- wild type do, and mutants are resistant to the stimulation
of egg laying by serotonin (Waggoner et al. 1998).tive egg-laying phenotype, defined in these assays as
worms that lay eggs at or before the four-cell stage. egl-8 TPA-1 acts in and is expressed in vulval muscle and in
the nervous system (Waggoner et al. 2000). Although(sa47) and egl-8(n488) mutants exhibited an egg-laying-
defective phenotype as single mutants; however, these egg-laying defects are evident in single-worm tracking
assays over long periods, the developmental stage ofmutations did not significantly suppress egl-30(gf) muta-
tions with respect to egg-laying behavior (Table 3). eggs laid by tpa-1 mutants did not differ from wild-type
worms (Table 3). Mutations also do not suppress egl-30Some level of mutual suppression appeared to be gener-
ally true with respect to movement since egl-30(gf); egl-8 (gf) mutations with respect to the developmental stage
of eggs laid (Table 3). We conclude from these resultsdouble mutants still moved with exaggerated body
bends, but activity levels appeared slightly reduced (data that tpa-1 either is not downstream of egl-30 or functions
redundantly with another gene downstream of egl-30.not shown). egl-30(md186sy679); egl-8(sa47) double mu-
tants did display a further reduction in egg-laying behav- egl-30(md186sy676); itr-1 double mutants also did not
display significant differences with respect to egg layingior, which is expected if these genes act in parallel. The
apparent increase in egg-laying activity exhibited by egl- compared with egl-30(gf) single mutants. itr-1(sa73) mu-
tants have reduced brood sizes, but the stage of eggs30(md186); egl-8(sa47) mutants, on the basis of hatched
larvae observed on the plate, is not absolutely under- laid by these worms is similar to wild type (Table 3).
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itr-1(sa73) encodes a C1525Y change in the central mod- sent the null allele of egl-8 since it encodes a Q85Term
change in exon 2 (Lackner et al. 1999). However, theulatory domain (Dal Santo et al. 1999). We did not
use a null allele for our analysis since null alleles exhibit egg-laying defect exhibited by egl-8(sa7) mutants is not
as severe as the defect exhibited by egl-8(n488) mutantsa sterile phenotype (Dal Santo et al. 1999). These re-
sults indicate that egl-30(gf) can also bypass the require- (Table 3). Furthermore, egl-8(sa47) responds to the stim-
ulation of egg-laying behavior by 5-HT and egl-8(n488)ment for itr-1 with respect to the regulation of egg-laying
behavior. does not (Table 2). The weaker defects exhibited by
egl-8(sa47) mutants might be explained by the presenceMutations in the PLC gene and in genes encoding
components described as downstream of PLC con- of alternative downstream transcriptional initiation sites
or by readthrough past the termination codon. In thisferred a weak, but insignificant, suppression of the hy-
peractive egg laying conferred by egl-30(md186sy676) case, egl-8(n488) mutants might better represent the null
phenotype of egl-8. The endpoints of the deletion in egl-mutations. We conclude that this pathway either is a
minor component downstream of EGL-30 or functions 8(n488) (see Figure 4) predict exons 10 and 11 are
deleted, thus disrupting the reading frame (Miller etcompletely in parallel to EGL-30 with respect to egg
laying. al. 1999). Exons 10 and 11 correspond to a portion of
the region between the catalytic X and Y domains, andPLC is likely a major component downstream of
EGL-30 with respect to pharyngeal pumping behavior: it is possible that a protein of altered function is pro-
duced. To examine the molecular nature of the egl-8On the basis of defects in pumping exhibited by egl-30(rf)
mutants and of expression of egl-30 in the pharyngeal alleles, we performed Western analysis using the three
mutant alleles of EGL-8 that were used in this study.muscle, EGL-30 may act in pharyngeal muscle to regu-
late pharyngeal pumping behavior (Brundage et al. Consistent with the hypothesis that egl-8(sa47) repre-
sents a null allele, Western analysis using a carboxy-1996; Figure 1). Genetic interactions among egl-30 muta-
tions and egl-8(sa47), itr-1(sa73), and unc-13(e51) muta- terminal antibody produced against residues 1041–1382
(Miller et al. 1999) indicated that the extracts obtainedtions were also examined with respect to pharyngeal
pumping behavior (Table 4). In contrast to the insig- from the egl-8(sa47) mutants did not contain EGL-8 or
contained undetectable amounts of the complete pro-nificant effect of these mutations on the constitutive
egg-laying behavior conferred by egl-30(gf) mutations, tein (Figure 5). The faint band present in egl-8(sa47)
extracts that migrates slightly faster than the EGL-8the interaction of these mutations on the hyperactive
pumping exhibited by egl-30(md186 sy676) mutations is band is also present in egl-8(n488) extracts. It is also
present, but partially obscured, in N2 and unc-13 ex-clear.
egl-30(md186sy676); egl-8(sa47) double mutants exhib- tracts. Furthermore, extracts from egl-8(sa47) did not
contain any additional smaller bands compared withited a pharyngeal-pumping rate that is similar to egl-8
(sa47) single mutants, suggesting that EGL-8 could be N2, egl-8(n488), or unc-13 mutant extracts, indicating
that egl-8(sa47) mutants do not produce protein froma primary effector for EGL-30. unc-13(e51) suppressed
pharyngeal pumping to a similar extent as egl-8(sa47), an alternative downstream start site.
An extra band also was not present in egl-8(n488),suggesting that these genes function in a common path-
way. itr-1(sa73) exhibits the most severe pumping defect consistent with antibody staining of whole worms de-
scribed previously (Miller et al. 1999). The differencesand accordingly exhibits the strongest suppression of
egl-30(md186sy676). The stronger effect of the itr-1 muta- in response of egl-8(n488) and sa47 and md1971 mutants
to 5-HT in egg-laying assays suggested that the egl-8tion on pumping rate, compared with egl-8 mutations,
may reflect the fact that ITR-1 responds to other recep- (n488) allele is neomorphic, so we determined the mo-
lecular lesion of n488 and inferred the effect on thetor pathways, such as the EGF receptor, LET-23 (Clan-
dinin et al. 1998; Bui and Sternberg 2002). We also reading frame in egl-8(n488) mutants on the basis of
deletion endpoints. We found that fusion of exons 9–12investigated the genetic interactions between egl-30
(md186) and egl-8(sa47) or unc-13(e51) and found that would produce a termination codon at amino acid resi-
due 681, just 44 amino acids after the last amino aciddouble mutants exhibited a roughly additive decrease in
overall pharyngeal pumping rate compared with single encoded in exon 9. Therefore, the hypothesis that egl-8
(n488) encodes the truncated protein of altered func-mutants. If egl-8(sa47) completely lacks EGL-8 activity,
and EGL-8 is the only direct effector for egl-30, then tion, that it contains an X domain but not a Y domain,
and that it is not recognized by the EGL-8 antibody todouble mutants are expected to exhibit a phenotype
not more severe than that of egl-8 single mutants. Conse- the carboxyl terminus is possible.
Like egl-8 null mutants, unc-13 mutants also exhibit aquently, we believe that although EGL-8 could represent
the primary effector for EGL-30 with respect to the response to serotonin in egg-laying assays that is compa-
rable to wild type (Table 2). This result lends supportregulation of pharyngeal pumping, it is likely that there
are also other minor downstream effector molecules to a hypothesis that egl-8 functions in a linear pathway
with unc-13 to regulate egg laying. Unlike loss of EGL-involved with the regulation of this behavior.
Analysis of egl-8 alleles: egl-8(sa47) is believed to repre- 30-regulated response pathways, loss of EGL-8- or UNC-
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Figure 4.—Gene and
protein domain structure of
EGL-8. (A) Exon/intron
structure, starting with the
first ATG and ending with
the stop codon within a cod-
ing region that extends
22,164 bp. Numbered ex-
ons are exons that have been
shown to be alternatively
spliced (Miller et al. 1999).
The solid line indicates the
region deleted in egl-8
(n488). The egl-8(n488) dele-
tion extends from an intron
212 bp after exon 9 to an
intron 434 bp after exon 11 (Miller et al. 1999; and see materials and methods). The catalytic X domain is contained within
exons 6–8, and the catalytic Y domain is contained within exons 12–13. (B) Domain structure of EGL-8, encoded by 1431-amino-
acid residues. The egl-8(n488) deletion extends between the X and Y catalytic domains, and the deleted region is indicated by
the solid line. () The position of mutations encoding early termination codons in sa47 (Lackner et al. 1999) and md1971
(Miller et al. 1999). The position of the md1971 mutation is slightly different within the context of the protein domain structure
from what was previously predicted.
13-mediated regulation of egg laying does not interfere exogenous addition of both serotonin and levamisole
(Waggoner et al. 1998).with serotonin response. In fact, cha-1 mutants also ex-
hibit increased sensitivity to serotonin (Schafer et al. egl-30 reduction-of-function mutants exhibit a re-
duced response to serotonin in egg-laying assays (Trent1996), lending support to the notion that acetylcholine
response pathways are directly coupled to egl-8 and unc- et al. 1983; Brundage et al. 1996). Like other egl-30
reduction-of-function mutants, egl-30(md186) displayed13 with respect to egg laying.
egl-30 function in vulval muscle: Our expression analy- a reduced response to serotonin (Table 2). On the basis
of the neuron ablations described above, if nervous sys-sis revealed only rare expression of egl-30 in the vulval
muscles (evident in 10% of adult animals). We sought to tem but not muscle function is compromised in egl-30
mutants, then reduction-of-function mutants should re-determine whether the low expression levels reflected
a true site-of-action for egl-30 in the vulval muscles. Vul- spond to serotonin and levamisole in egg-laying assays.
In contrast to animals that lack the motor neurons thatval muscle expression of egl-8 has not been previously
reported and to facilitate the interpretation of our dou- innervate the vulval muscle, egg laying was not restored
in egl-30(md186) mutants or in the stronger reduction-ble-mutant analysis, we wanted to determine whether
EGL-8 might have a site-of-action in the vulval muscles. of-function mutant, egl-30(ad805) (data not shown)
The egg-laying system of C. elegans consists of the vulval
muscles with direct innervation from two classes of mo-
tor neurons, the VCs and the HSNs (White et al. 1986;
Desai et al. 1988). Dominant mutations in egl-1 cause
the cells that would normally be destined to become
the HSN motor neurons to undergo programmed cell
death (Ellis and Horvitz 1986). In wild-type hermaph-
rodites, genetic ablation of the HSNs, via egl-1 mutations,
causes worms to lay eggs at a very late stage of devel-
opment (Trent et al. 1983; Ellis and Horvitz 1986;
Desai and Horvitz 1989). Ablation of the VC4 and
VC5 motor neurons alone does not have a drastic effect
on egg-laying behavior (Garriga et al. 1993; Waggoner
et al. 1998). However, laser ablation of the VC4 and VC5
motor neurons of egl-1 hermaphrodites during the L4
larval stage further compromises egg-laying behavior
and animals do not respond to the neurotransmitter
5-HT (Waggoner et al. 1998), normally a strong stimula-
tor of egg-laying behavior (Horvitz et al. 1982; Trent Figure 5.—Western analysis of egl-8 mutant protein extracts.
et al. 1983). Egg laying can be rescued in egl-1 animals Arrow indicates the band present from N2 and unc-13 mutant
extracts but not from egl-8(n488) or egl-8(sa47) mutant extracts.that have ablated VC4 and VC5 motor neurons with the
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the effects of serotonin either because EGL-30 couples
to a serotonin receptor or because EGL-30 is involved
with response or release of serotonin from the motor
neurons that innervate the vulval muscles. In mammals,
-methyl 5-HT stimulates 5-HT2 receptor subtypes
(Richardson et al. 1985; Ismaiel et al. 1990) that can
couple to mammalian Gq (Seuwen et al. 1988; Launay
et al. 1996). On the basis of stimulation by -methyl 5-HT,
5-HT2 receptors have been shown to mediate tonic firing
in pyramidal neurons of the rat prefrontal cortex
(Zhang 2003).
To investigate whether a receptor that exhibits a simi-
lar pharmacological response exists in C. elegans, we
tested the response of worms to -methyl 5-HT in egg-
laying assays. We found that wild-type worms exhibited
a robust response to -methyl 5-HT (Table 5B). In con-
trast, egl-30(md186) mutants did not respond to this ago-
nist (Table 5B). egl-30(md186sy676) mutants cannot be
accurately tested since they immediately laid eggs when
placed in water, and the activity of this agonist is inhib-
ited in M9, similar to dopamine and dopamine antago-
nists (Weinshenker et al. 1995). However, egl-30(md186Figure 6.—Tetramethyl rhodamine isothiocyanate-phalloi-
din staining of N2 and egl-30 (ad805) adults to visualize actin sy676); egl-1 double mutants exhibited a similar or
filaments. Staining was performed as described in materials higher response to -methyl 5-HT compared with egl-1
and methods. BM, body-wall muscle; VM, vulval muscle. Bars, single mutants (Table 5B). We then compared the re-10m. (A) The vulval muscle structure of a wild-type hermaph-
sponse to 5-HT and -methyl 5-HT of syIs36, a strainrodite, lateral view. (B) The vulval muscle structure of an egl-
that overexpresses wild-type egl-30. As shown in Table30(ad805) mutant, ventral view.
5, A and C, syIs36 exhibited similar responses to both
-methyl 5-HT and 5-HT as egl-30(md186sy676) mutants.
These results suggest that EGL-30 mediates response to
when treated with exogenous serotonin and levamisole a 5-HT2-type receptor to regulate egg laying. Finally, on
(Table 2). Like egl-30 mutants, egg laying was not res- the basis of the observation that a response was elicited
cued in egl-8(n488) mutants with serotonin and levami- from egl-1 mutants, we conclude that an -methyl 5-HT-
sole (Table 2), also indicating a previously unsuspected responsive receptor functions either in a VC-dependent
role for EGL-8 in vulval muscle (Table 2). neuronal pathway or in the vulval muscle.
Two simple possibilities could explain the reduced If, as we propose, serotonin is required for EGL-30-
response of egl-30 and egl-8 mutants to serotonin and induced egg-laying behavior, then egl-30(md186sy676)
levamisole. First, egl-30 and egl-8 might have a cell-auton- mutants that lack endogenous serotonin should not ex-
omous site of action in the vulval muscle. Second, when hibit constitutive egg laying. To further test this hypothe-
function of the protein is reduced throughout develop- sis, we analyzed epistasis between egl-30(gf) and tph-1(lf)
ment, muscle development or function might be com- mutants. tph-1(mg280) mutants lack detectable serotonin
promised. However, the actin structure of egl-30 mutants because of a defect in tryptophan hydroxylase, an en-
appears to be intact on the basis of phalloidin staining zyme involved in serotonin biosynthesis (Sze et al. 2000).
(Figure 6). Also, the contractile apparatus of the pharyn- tph-1 mutants lay late-stage eggs (Sze et al. 2000), but
geal muscle in the putative null mutant, egl-30(ad810), tph-1 mutants were not as defective in egg laying as egl-1
is still functional, on the basis of the ability of the pharyn- mutants (Table 6). egl-30(gf); tph-1 double mutants dis-
geal muscle to contract in response to laser stimulation played an egg-laying defect that is similar to tph-1 single
of the plasma membrane (Brundage et al. 1996). We mutants. This result suggests a direct linear pathway
conclude that the function of the muscle is more likely between serotonin response and EGL-30 function and
compromised with respect to the ability to transduce a indicates that egl-30(md186sy676) cannot bypass the re-
signal. quirement for serotonin with respect to egg-laying be-
egl-30(md186sy676) cannot bypass the requirement for havior. However, tph-1 mutants were not as defective in
serotonin with respect to egg laying: Serotonin is the egg laying as egl-30 mutants (Tables 1 and 6B). Consis-
primary neurotransmitter that potentiates egg laying tent with the partial suppression of egl-30(md186sy676)
(Desai and Horvitz 1989) and egl-30(rf) mutants are by unc-13 (Table 3), acetylcholine may represent an-
resistant to the effects of serotonin in egg-laying assays other minor regulatory pathway associated with egl-30
(see discussion).(Table 2). Thus, egl-30(rf) mutants might be resistant to
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TABLE 5
Response of mutants to serotonin agonists
5-HT N SD
A. Response to 7.5 mm serotonin (5-HT)
N2 5 23 2.7
egl-30(md186sy676) 1.6 20 1.5
egl-1 19.2 15 8.7
egl-30(md186sy676); egl-1 12.5 14 5.9
syls36 1.4 12 1.1
-Methyl N SD ddH2O N SD
B. Response to -methyl 5-HT, a 5-HT2 receptor agonist
N2 15 10 3.8 1.3 15 1.2
egl-30(md186) 1 8 2 NA 8
egl-30(md186sy676)a 5.3 15 2.5 5.4 10 3.8
egl-1 15 8 4.2 1.1 8 2.4
egl-30(md186sy676); egl-1a 19.3 10 3.2 3.6 10 2.4
C. Response of syls36 to -methyl 5-HT
N2 19.5a,* 8 8.2 6.5 8 5.1
syls36 3.4b,** 14 2.4 0.4 12 0.7
(A) Individual worms were assayed in M9 solution at room temperature. Eggs were counted after 90 min.
(B) Individual worms were assayed in a solution of 1 mm -methyl 5-HT in water at room temperature. Eggs
were counted after 1 hr.
(C) Single worms were assayed in a total volume of 200 l. Eggs were counted after a 90-min incubation at
room temperature. Approximately 2 out of 10 animals from each genotype exploded in water over this longer
time period, and these animals were not included in the assay. Two-tailed P values (Mann-Whitney U-test
nonpaired comparisons of experimental to water controls) are indicated for each value due to high responses
in water: *P 
 0.008, very significant; **P 	 0.0001, extremely significant. NA, not applicable; this strain
explodes in ddH2O. SD, standard deviation per worm.
a Hermaphrodites laid more eggs than wild type in water. The response to egl-30(md186sy676) mutants is not
significant, and this is due to its high response in water.
b Two of 10 animals exploded when placed in water.
The HSNs are the primary serotonergic motor neu- bers of the Gq family that share 88% sequence identity
rons that regulate egg laying. Accordingly, egl-1 mutants with one another, are coexpressed in almost every cell
exhibit a severe egg-laying defect. However, egl-1 single type (Wilkie et al. 1991). The other Gq subunits are
mutants exhibit a more severe egg-laying defect than expressed in a more restricted pattern (Amatruda et
do egl-30(gf); egl-1 double mutants (Table 6A), indicating al. 1991; Wilkie et al. 1991). Like C. elegans EGL-30,
that EGL-30 can partially bypass the requirement for the vertebrate Gq family is required for viability since
the HSNs. This result is evident even with the stronger targeted disruption of both Gq and G11 results in
gain-of-function allele, egl-30(tg26), that does not con- embryonic lethality at embryonic day 11 (Offermanns
tain the egl-30(md186) mutation in the background. Epis- and Simon 1998).
tasis with tph-1, but not with egl-1, is likely due to the The expression pattern of egl-30 suggests that EGL-
fact that the VC motor neurons are also known to be 30 functions in many cell types and likely has a role
weakly serotonergic (Duerr et al. 1999). We infer that throughout development. As larval development begins
egl-30 does function in or via the HSN motor neurons. and progresses, we found that expression levels of egl-
However, since EGL-30 can partially bypass the HSN 30 generally increased with the highest expression in L4
neurons, a role for egl-30 either in the VC motor neurons larvae and adult animals. Its earliest role in development
or in the muscle is indicated. was previously presumed to be during larval develop-
ment since mutations that should abort translation at
Trp212 or Trp259 (ad810 and ad813) arrest at various
DISCUSSION stages during larval development (Brundage et al.
1996). However, the rolling movement of embryos dur-The expression pattern reported here indicates that
ing embryonic elongation was found to be indistinguish-egl-30 is broadly expressed, consistent with its pleiotropic
function. Similarly, vertebrate Gq and G11, two mem- able from wild type, and some of these animals were
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TABLE 6
Interaction of egl-30(gf) mutations with egl-1 mutations and with mutations in tph-1
A. Genotype HSN? 2c–4c 5c-gastr. Comma 2-fold Pretzel Hatched N
N2  100 Many
egl-30(md186sy676)  52 48 199
egl-30(tg26)  91 9 38
egl-1 — 6 3 66 25 61
egl-30(md186sy676); egl-1 — 18 12 5 48 17 60
egl-30(tg26); egl-1 — 86 14 49
B. Genotype 2–4C 5c-gastr. Comma 2-fold Pretzel N
egl-30(sy676) 52 48 199
tph-1; him-5 57 26 16 135
egl-30(md186sy676); tph-1; him-5 63 7 3 27 59
egl-1 mutations result in genetic ablation of the HSN motor neuron, the primary serotonergic motor neuron
that regulates egg laying. tph-1 mutations eliminate detectable levels of serotonin. 2c–4c, two- to four-cell stage.
Egg-laying assays were performed as described in materials and methods. 5c-gastr., five-cell stage embryo to
gastrulating embryo. (A) Genetic ablation of the HSN motor neurons suppressed constitutive egg laying of
egl-30(gf) mutations; egl-30(gf) mutations partially suppressed the Egl-D phenotype exhibited by egl-1 mutants.
(B) tph-1 was epistatic to egl-30(sy676) with respect to egg-laying behavior.
also able to develop to semifertile adults (Brundage et induced arecoline hypersensitivity (Brundage et al.
1996). Lackner et al. (1999) later found that overex-al. 1996). We speculate that since embryos express only
low levels of egl-30, low levels of translational read- pression of constitutively active EGL-30, EGL-30(QL),
in the motor neurons of the ventral cord is sufficientthrough (as indicated by the ability of some animals to
develop into adults) or maternal rescue from heterozy- to alter the locomotion of wild-type animals and results
in enhanced sensitivity to the acetylcholinesterase inhib-gous mothers is sufficient to rescue embryonic develop-
ment. We also speculate that the general increase in itor, aldicarb (Lackner et al. 1999). On the basis of
expression pattern, HSN ablations, and pharmacologi-expression levels of egl-30 during larval development,
revealed by the GFP fusion transgene, reflects a require- cal analysis with egl-30 mutants, we found that egl-30
likely acts in or via neurons and in muscle during eggment for increased activity levels as animals develop.
This hypothesis is supported by the larval arrest pheno- laying.
However, our unpublished experiments suggest thattype exhibited by egl-30(ad810 and ad813) mutants.
Expression and site of action of egl-30: In L4 larvae C. elegans is not tolerant to overproduction of egl-30 in
muscle cells, on the basis of our attempts using muscle-and in adult animals, egl-30 is expressed at highest levels
in the nervous system and then in the pharyngeal mus- specific heterologous promoter elements such as myo-3
(body wall), myo-2 (pharyngeal muscle), and hlh-8 (M-cellcle. In spite of the rare expression observed in the vulval
muscle, the pharmacological response of egl-30 mutants lineage specific; Harfe et al. 1998). We infer that these
transgenes confer lethality on the basis of the inabilityin egg-laying assays indicates that EGL-30 also functions
in the vulval muscle. Antibody staining also revealed to obtain stably inherited transgenic lines. On the basis
of GFP reporter analysis, the myo-2 enhancer confersconsistent expression in the anal sphincter muscle,
which is consistent with a weak defect that egl-30 reduc- very high levels of expression in the pharyngeal muscle.
We conclude that, especially for this expression con-tion-of-function mutants exhibit with respect to defeca-
tion (Miller et al. 1996). Rare expression was also ob- struct, it is difficult to titrate levels low enough to obtain
viable stable lines. Accordingly, arrested eggs were oftenserved in the head muscles and in body wall muscle,
and the role for egl-30 in these tissues remains to be observed to express the myo-2::GFP expression construct
that was coinjected with the myo-2::egl-30 expression con-explored.
Initial analysis regarding the site of action for EGL- struct. A few worms that we examined exhibited slow
pharyngeal pumping, which might have mimicked what30 indicated that EGL-30 has a general site of action in
the muscle, i.e., pharyngeal, vulval, or uterine, and in would be expected from high levels of overexpression
since egl-30(tg26) and syIs36 exhibit irregular pumpingthe body (Brundage et al. 1996). Specifically, ablation
of the pharyngeal neurons, with the exception of the (data not shown). A minimal artificial construct derived
from the ceh-24 promoter element that contained onlyessential M4 neuron, suggests that egl-30 functions in
the muscle with respect to the suppression of gpb-2- a GAGA box and two NdE boxes is expected to confer
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only vulval-muscle-specific expression (Harfe and Fire pared to egl-30 mutants accurately reflects the nonover-
lapping roles of these two genes. Clear epistasis was1998). When we fused this element to the minimal myo-2
promoter element to drive expression of egl-30, stable observed with tph-1 mutations with respect to egg laying.
Since tph-1 mutants exhibited an egg-laying defect thatlines were obtained only at a concentration of 0.05 ng/
l and the lines obtained did not exhibit a phenotype is similar to egl-8(sa47) mutants, and since tph-1 mutants
are less impaired with respect to egg laying than areand transmitted the array at a low frequency (see also
Moghal et al. 2003). The low level of egl-30 expression egl-8(n488) mutants, these gain-of-function alleles do re-
tain specificity with respect to their response pathways.that we observed in muscle is consistent with the possi-
bility that high levels of expression are lethal. It may There are no other clear PLC homologs in C. elegans.
The next most closely related predicted protein isalso be consistent with the possibility that egl-30 does
not actually function in muscle cells, which would indi- Y75B12b.6 (Miller et al. 1999). Y75B12b.6 lacks a C2
domain on the basis of SMART and Pfam analysis ofcate that the reduced function of the nervous system in
egl-30 mutants affects the function of the vulval muscle the predicted protein. The C2 domains of PLC1 and
PLC2 have been shown to mediate an interaction within a non-cell-autonomous fashion.
EGL-30- and EGL-8-signaling pathways: EGL-8 is ge- Gq (Wang et al. 1999). Deletion analyses have revealed
that the C-terminal 400 amino acids of PLC1 (Parknetically downstream of EGL-30 with respect to acetyl-
choline release at neuromuscular junctions (Lackner et al. 1993; Wu et al. 1993) and PLC2 (Lee et al. 1993)
are critical for their interaction with Gq, but not criticalet al. 1999). However, we believe that EGL-8 is not the
only effector for EGL-30. Aside from the observation for their interaction with . Further studies have pin-
pointed specific amino acid residues of PLC1 criticalthat egl-30 and egl-8 expression do not overlap in pharyn-
geal muscle (Miller et al. 1999), slight differences in for interaction with Gq (Kim et al. 1996) and for dimer-
ization of the PLC C-terminal domain (Singer et al.the subcellular localization of EGL-30 and EGL-8 indi-
cate that EGL-30 probably interacts with effectors other 2002). Dimerization has also been proposed to be im-
portant for regulation by Gq (Singer et al. 2002). Thesethan EGL-8. Like EGL-30, EGL-8 is broadly expressed
in the nervous system, with strong expression in neu- regions contain a high level of similarity with other
PLCs, but the C-terminal region of Y75B12b.6 doesronal cell bodies (Miller et al. 1999). In contrast, the
strongest expression of EGL-30 was evident in neuronal not contain similarity within these critical determinants
for interaction with Gq.cell processes (Figure 1).
Genetic interactions of egl-30(gf) mutations with muta- We conducted a BLAST search of the genome se-
quence available in WS84 using the C-terminal 400tions in egl-8 and with the genes that act downstream
of egl-8 also support the conclusion that PLC is at most amino acids of PLC1, PLC2, PLC3, and PLC4. On
the basis of sequence alignments, the C-terminal 400a minor component downstream of Gq signaling in C.
elegans with respect to egg-laying behavior. However, the amino acids contain the regions in PLC1 and PLC2
that are required for interaction with Gq and the corre-genetic data do not eliminate the possibility that EGL-8
is the primary effector for EGL-30 in the nervous system, sponding regions in PLC3 and PLC4. Using a proba-
bility cutoff of 105, none of the hits obtained, with theif egl-30 functions in the vulval muscle and egl-8 does
not, since the final behavioral readout is ultimately de- exception of EGL-8, were putative PLC homologs. In
fact, some of the proteins with significant similarity werependent on muscle activity. We do not believe this for
the following reasons. Pharmacological data indicate related to muscle component proteins. As shown in
Figure 6, the actin structure of egl-30(ad805) mutantsthat both egl-30 and egl-8 might function in vulval mus-
cle. More importantly, C. elegans are extremely sensitive appears normal compared to wild type. We believe that
it is likely that other effectors for EGL-30 interact withto EGL-30 activity levels. If EGL-8 is a primary effector
for EGL-30 in the nervous system, then loss-of-function a domain that is distinct from the PLC interaction
domain.mutations in egl-8 would be expected to exert strong
suppression of nervous system function. Double-mutant EGL-30 and serotonin signaling: While it is possible
that the acetylcholine/EGL-8 pathway represents oneanalysis of egl-30(gf) mutations with mutations in egl-1
and with tph-1 indicate that if egl-30 functions in the of the minor pathways downstream of egl-30 with respect
to egg laying, it is likely that this pathway would actvulval muscle, muscle function is not sufficient to confer
constitutive egg laying. in parallel to modulate the more significant serotonin-
responsive and egl-8-independent pathway downstreamSince egl-8 mutations are clearly epistatic to egl-30(gf)
mutations with respect to pharyngeal pumping, we do of egl-30. For example, egl-8 and unc-13 reduction-
of-function mutants, implicated in acetylcholine release,not believe that the gain-of-function EGL-30 mutant
proteins promiscuously activate downstream effector are sensitive to serotonin, like cha-1 mutants (Schafer
et al. 1996) and unlike egl-30 mutants. However, egl-30molecules that do not normally interact with wild-type
EGL-30. We also believe that we have demonstrated that mutants are essentially resistant to the stimulation of
egg laying by serotonin in egg-laying assays. Moreover,the egl-8(sa47) allele represents a null allele, and so the
weaker phenotype exhibited by egl-8 null mutants com- mutations in tph-1 that result in a loss of detectable
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by a Department of Health and Human Services National Researchlevels of serotonin are epistatic to egl-30 gain-of-function
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macological data support the possibility that EGL-30 is
coupled to a serotonin receptor. One such candidate
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